News

The agreement provides Abbott with exclusive worldwide rights to Antibody 806, which targets the clinically validated pathway involving the epidermal growth factor receptor (EGFr). Antibody 806 is differentiated

Venlafaxine HCl extended-release capsules, indicated for the treatment of major depressive disorder and generalized anxiety disorder, are the generic version of Wyeth Pharmaceutical’s Effexor XR capsules. Currently, Mylan

This agreement establishes MedX as the exclusive provider of low level laser and light technology to Naimco/Rich-Mar and will allow MedX Health to sell components to Naimco/Rich-Mar that

The alliance between Patheon and Senopsys is intended to deliver patient accepted pediatric formulations, line extension products and reformulated pharmaceutical products. These products will be optimized for palatability

Sorin Group and Sphere Medical have undertaken a feasibility study which included an evaluation of Sphere Medical’s microsensor technology in animal and human blood. Following the successful conclusion

Abingdon will utilize the resources of Stason Pharma Japan to enhance its business development and intellectual property licensing opportunities in Asia. Abingdon will also offer strategic planning, clinical

The Freedom-C trial was a randomized, double-blind, placebo-controlled trial of patients with severe pulmonary arterial hypertension (PAH). The study population consisted of 354 patients who were optimized on

Under the terms of the agreements, United Therapeutics will make an upfront payment of $150 million to Lilly for the exclusive rights to commercialize tadalafil for pulmonary arterial

By combining Philips Research’s strengths in microelectronics, signal processing, ultra-low power system design and miniaturization with NeuroNexus Technologies’s expertise in micro-scale electrode design and fabrication, the two companies